CELEBRATING JEWELLERY WITH PURPOSE
This milestone is the result of the successful, long-term partnership between Paspaley and Garvan. This funding has gone to support the Molecular Screen and Therapeutics (MoST) clinical trial program, a program for people with rare and less common cancers who have exhausted all other treatment options
This funding has enabled:
175 patients to undergo molecular screening as part of the clinical trial
1,450 patients received a recommendation for personalised treatment based on their profile
Half of all patients who received a matched therapy, now double their life expectancy
Paspaley are proud and appreciative of the contribution from our community, that has been able to change the lives of cancer patients through this partnership.
Discover The Kimberley Bracelet.